MedPath
FDA Approval

Imipenem and Cilastatin

October 11, 2022

HUMAN PRESCRIPTION DRUG LABEL

Imipenem(250 mg in 20 mL)
Cilastatin(250 mg in 20 mL)

Manufacturing Establishments (2)

Zambon Switzerland Ltd

Fresenius Kabi USA, LLC

481761344

ACS Dobfar S.p.A.

Fresenius Kabi USA, LLC

439962157

Products (2)

Imipenem and Cilastatin

63323-349

ANDA090577

ANDA (C73584)

INTRAVENOUS

August 31, 2020

ImipenemActive
Code: 71OTZ9ZE0AClass: ACTIMQuantity: 250 mg in 20 mL
SODIUM BICARBONATEInactive
Code: 8MDF5V39QOClass: IACTQuantity: 10 mg in 20 mL
Code: 5428WXZ74MClass: ACTIMQuantity: 250 mg in 20 mL

Imipenem and Cilastatin

63323-322

ANDA090577

ANDA (C73584)

INTRAVENOUS

August 31, 2020

Code: 5428WXZ74MClass: ACTIMQuantity: 500 mg in 20 mL
SODIUM BICARBONATEInactive
Code: 8MDF5V39QOClass: IACTQuantity: 20 mg in 20 mL
ImipenemActive
Code: 71OTZ9ZE0AClass: ACTIMQuantity: 500 mg in 20 mL
© Copyright 2025. All Rights Reserved by MedPath